| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases
|
Schett, Georg
|
|
2010
|
|
5 |
p. 271-278
|
article
|
| 2 |
Atherosclerosis in psoriatic disease: latest evidence and clinical implications
|
Eder, Lihi
|
|
2015
|
|
5 |
p. 187-195
|
article
|
| 3 |
Best performing definition of accelerated knee osteoarthritis: data from the Osteoarthritis Initiative
|
Driban, Jeffrey B.
|
|
2016
|
|
5 |
p. 165-171
|
article
|
| 4 |
Bone disease in primary hyperparathyrodism
|
Marcocci, Claudio
|
|
2012
|
|
5 |
p. 357-368
|
article
|
| 5 |
Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach
|
Hodkinson, Bridget
|
|
2016
|
|
5 |
p. 172-179
|
article
|
| 6 |
Combination therapy with biologic agents in rheumatic diseases: current and future prospects
|
Inui, Kentaro
|
|
2016
|
|
5 |
p. 192-202
|
article
|
| 7 |
Controversies and challenges in fibromyalgia: a review and a proposal
|
Cohen, Helen
|
|
2017
|
|
5 |
p. 115-127
|
article
|
| 8 |
DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug
|
Bello, Alfonso E.
|
|
2012
|
|
5 |
p. 327-339
|
article
|
| 9 |
Experience with subcutaneous abatacept for rheumatoid arthritis: an update for clinicians
|
Khraishi, Majed M.
|
|
2014
|
|
5 |
p. 159-168
|
article
|
| 10 |
Making the next steps in psoriatic arthritis management: current status and future directions
|
Sritheran, Diviya
|
|
2015
|
|
5 |
p. 173-186
|
article
|
| 11 |
Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations
|
Tournadre, Anne
|
|
2016
|
|
5 |
p. 180-191
|
article
|
| 12 |
Managing hip and knee osteoarthritis with exercise: what is the best prescription?
|
Iversen, Maura Daly
|
|
2010
|
|
5 |
p. 279-290
|
article
|
| 13 |
Medication-induced osteoporosis: screening and treatment strategies
|
Panday, Keshav
|
|
2014
|
|
5 |
p. 185-202
|
article
|
| 14 |
Novel approaches in the treatment of myositis and myopathies
|
Albayda, Jemima
|
|
2012
|
|
5 |
p. 369-377
|
article
|
| 15 |
Opioids in chronic musculoskeletal conditions
|
Calvo-Alén, Jaime
|
|
2010
|
|
5 |
p. 291-297
|
article
|
| 16 |
Role of diagnostic ultrasound in the assessment of musculoskeletal diseases
|
Patil, Pravin
|
|
2012
|
|
5 |
p. 341-355
|
article
|
| 17 |
Sarcoidosis: a rheumatologist’s perspective
|
Kobak, Senol
|
|
2015
|
|
5 |
p. 196-205
|
article
|
| 18 |
Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes
|
Smith, Jessica W.
|
|
2012
|
|
5 |
p. 315-325
|
article
|
| 19 |
Strontium ranelate in the treatment of knee osteoarthritis: new insights and emerging clinical evidence
|
Reginster, Jean-Yves
|
|
2013
|
|
5 |
p. 268-276
|
article
|
| 20 |
The calcium and vitamin D controversy
|
Abrahamsen, Bo
|
|
2017
|
|
5 |
p. 107-114
|
article
|
| 21 |
The role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in modern rheumatology
|
Kotyla, Przemyslaw
|
|
2010
|
|
5 |
p. 257-269
|
article
|
| 22 |
The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis
|
Srirangan, Srinivasan
|
|
2010
|
|
5 |
p. 247-256
|
article
|
| 23 |
Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications
|
Cribbs, Adam
|
|
2015
|
|
5 |
p. 206-219
|
article
|
| 24 |
Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidence
|
Sim, Ie-Wen
|
|
2013
|
|
5 |
p. 259-267
|
article
|
| 25 |
Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know
|
Krause, Megan L.
|
|
2014
|
|
5 |
p. 169-184
|
article
|
| 26 |
Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential
|
Gottlieb, Alice
|
|
2013
|
|
5 |
p. 277-285
|
article
|
Journal description